** Shares in DSM-Firmenich DSFIR.AS rise 3.7% after the European chemical maker posted higher Q1 core profit and reiterated its 2026 FY guidance, driven by demand for fine fragrance ingredients and earlier orders
** Co's Q1 EBITDA grew 4% on a like-for-like basis to 434 million euros ($509.2 million), slightly beating analyst estimates of 431 million euros
** Reported sales fell 3% to 2.28 billion euros due to a currency impact and portfolio changes
** KBC Securities welcomes the increased focus on shareholder remuneration and continues to value DSM's broad portfolio and leading positions in consumer-oriented businesses
** Up to the previous session's close, shares were down 6.9% YTD
($1 = 0.8524 euros)
(Reporting by Hugo Lhomedet)
((hugo.lhomedet@thomsonreuters.com))